Cited by 115Health Systems, Economic Evaluations, Quality of LifeOphthalmology and Visual Impairment StudiesRetinal Imaging and Analysis

The DOI matches its Crossref record; 19 of the 28 references it cites were found in a registry or an index, and 9 are not checked yet.

Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis

Open access

Abstract

Background More than 90% of vision impairment is avoidable. However, in China, a routine screening programme is currently unavailable in primary health care. With the dearth of economic evidence on screening programmes for multiple blindness-causing eye diseases, delivery options, and screening frequencies, we aimed to evaluate the costs and benefits of a population-based screening programme for multiple eye diseases in China. Methods We developed a decision-analytic Markov model for a cohort of individuals aged 50 years and older with a total of 30 1-year cycles. We calculated the cost-effectiveness and cost-utility of screening programmes for multiple major blindness-causing eye diseases in China, including age-related macular degeneration, glaucoma, diabetic retinopathy, cataracts, and pathological myopia, from a societal perspective (including direct and indirect costs). We analysed rural and urban settings separately by different screening delivery options (non-telemedicine [ie, face-to-face] screening, artificial intelligence [AI] telemedicine screening, and non-AI telemedicine screening) and frequencies. We calculated incremental cost-utility ratios (ICURs) using quality-adjusted life-years and incremental cost-effectiveness ratios (ICERs) in terms of the cost per blindness year avoided. One-way deterministic and simulated probabilistic sensitivity analyses were used to assess the robustness of the main outcomes. Findings Compared with no screening, non-telemedicine co…

Overview

Integrity signals

Registry

Crossref · 10.1016/s2214-109x(22)00554-x

Cites

19 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Zhang, 2016, The evaluation of the mortality and life expectancy of Chinese population, Popul J, 38, 18

Cited by

Sorted by citations

Metadata

Authors
Liu, H., Li, R., Zhang, Y., Zhang, K., Yusufu, M., Liu, Y., Mou, D., Chen, X., Tian, J., Li, H., Fan, S., Tang, J., & Wang, N.
Affiliations
  • Beijing Institute of Technology (CN)
  • Beijing Tongren Hospital (CN)
  • The University of Melbourne (AU)
  • Han Dan City Eye Hospital - The Third Hospital of Handan (CN)
  • Renmin University of China (CN)
Venue
The Lancet Global Health
Publisher
Elsevier BV
Published
2023-03
Volume
11
Issue
3
Pages
e456-e465
ISSN
2214-109X (ISSN-L)
OpenAlex
W4317790704
Cited by
111
References
28
Citations by year
2026: 32 · 2025: 42 · 2024: 29 · 2023: 8
FWCI
22.60
Type
journal article
Language
en
Open access
Locations
  • The Lancet Global Health (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Greater South Information System
Funders
National Natural Science Foundation of China (82171051)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
blindness prevention, cost-effectiveness, age-related macular degeneration, glaucoma, diabetic retinopathy, cataract, pathologic myopia, telemedicine screening, artificial intelligence screening, urban-rural differences, visual impairment, China, Markov model, quality-adjusted life years, screening frequency, primary care
MeSH terms
Cost-Effectiveness Analysis, Aged, Artificial Intelligence, China, Cost-Benefit Analysis, Glaucoma, Humans, Middle Aged, Ophthalmology, Telemedicine, Quality-Adjusted Life Years

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review